Paper21396722
Vasoactive intestinal peptide receptor 1 is downregulated during expansion of antigen-specific CD8 T cells following primary and secondary Listeria monocytogenes infections.
Vomhof-DeKrey EE and 2 others. J Neuroimmunol, 2011. Cited by 6 papers, by iCite.
Cite this record
ConductScience Library. Vasoactive intestinal peptide receptor 1 is downregulated during expansion of antigen-specific CD8 T cells following primary and secondary Listeria monocytogenes infections. Papers, record 21396722. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/21396722
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Vasoactive intestinal peptide receptor 1 is downregulated during expansion of antigen-specific CD8 T cells following primary and secondary Listeria monocytogenes infections.
- PubMed
Topics18
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| CD8-Positive T-Lymphocytes | Major topic |
| Down-Regulation | Major topic |
| Listeriosis | Major topic |
| Receptors, Vasoactive Intestinal Polypeptide, Type I | Major topic |
| Adoptive Transfer | |
| Animals | |
| Antibodies | |
| CD3 Complex | |
| Cyclic AMP | |
| Enzyme-Linked Immunosorbent Assay | |
| Flow Cytometry | |
| Mice | |
| Mice, Inbred C57BL | |
| Mice, Transgenic | |
| RNA, Messenger | |
| Thy-1 Antigens | |
| Time Factors | |
| Vasoactive Intestinal Peptide |
Source PubMed
Grants4
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| K01 DK064828 | NIDDK NIH HHS | United States | K01DK064828 | PubMed and NIH | NIH RePORTER |
| P20 RR015566 | NCRR NIH HHS | United States | P20RR015566 | PubMed and NIH | NIH RePORTER |
| P30 GM103332 | NIGMS NIH HHS | United States | P30GM103332 | PubMed and NIH | NIH RePORTER |
| P20 RR015566-07 | NCRR NIH HHS | United States | P20RR015566 | PubMed and NIH | NIH RePORTER |
References45
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 18534815 | TCR signaling and environment affect vasoactive intestinal peptide receptor-1 (VPAC-1) expression in primary mouse CD4 T cells. | Brain Behav Immun | 2008 | https://conductscience.org/library/papers/18534815 | PubMed |
| 2 | 16365400 | Granzyme B, a new player in activation-induced cell death, is down-regulated by vasoactive intestinal peptide in Th2 but not Th1 effectors. | J Immunol | 2006 | https://conductscience.org/library/papers/16365400 | PubMed |
| 3 | 11935374 | TH2 lymphocytes secrete functional VIP upon antigen stimulation. | Arch Physiol Biochem | 2001 | https://conductscience.org/library/papers/11935374 | PubMed |
| 4 | 8021491 | In vivo T cell activation by anti-CD3 monoclonal antibody induces soluble TNF receptor release in mice. Effects of pentoxifylline, methylprednisolone, anti-TNF, and anti-IFN-gamma antibodies. | J Immunol | 1994 | https://conductscience.org/library/papers/8021491 | PubMed |
| 5 | 10337915 | VIP and PACAP inhibit IL-12 production in LPS-stimulated macrophages. Subsequent effect on IFNgamma synthesis by T cells. | J Neuroimmunol | 1999 | https://conductscience.org/library/papers/10337915 | PubMed |
| 6 | 4606296 | Candidate hormones of the gut. V. Vasoactive intestinal peptide (VIP). | Gastroenterology | 1974 | https://conductscience.org/library/papers/4606296 | PubMed |
| 7 | 19734220 | Induction of alloantigen-specific human T regulatory cells by vasoactive intestinal peptide. | J Immunol | 2009 | https://conductscience.org/library/papers/19734220 | PubMed |
| 8 | 11689474 | Allergic diathesis in transgenic mice with constitutive T cell expression of inducible vasoactive intestinal peptide receptor. | FASEB J | 2001 | https://conductscience.org/library/papers/11689474 | PubMed |
| 9 | 10975815 | Inhibition of IFN-gamma-induced janus kinase-1-STAT1 activation in macrophages by vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide. | J Immunol | 2000 | https://conductscience.org/library/papers/10975815 | PubMed |
| 10 | 10861043 | Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit T cell-mediated cytotoxicity by inhibiting Fas ligand expression. | J Immunol | 2000 | https://conductscience.org/library/papers/10861043 | PubMed |
| 11 | 7519212 | Human T lymphocyte chemotaxis and adhesion induced by vasoactive intestinal peptide. | J Immunol | 1994 | https://conductscience.org/library/papers/7519212 | PubMed |
| 12 | 6090573 | In vitro alteration of receptors for vasoactive intestinal peptide changes the in vivo localization of mouse T cells. | J Exp Med | 1984 | https://conductscience.org/library/papers/6090573 | PubMed |
| 13 | 19017950 | The Erk2 MAPK regulates CD8 T cell proliferation and survival. | J Immunol | 2008 | https://conductscience.org/library/papers/19017950 | PubMed |
| 14 | 11160313 | Selective gene expression and activation-dependent regulation of vasoactive intestinal peptide receptor type 1 and type 2 in human T cells. | J Immunol | 2001 | https://conductscience.org/library/papers/11160313 | PubMed |
| 15 | 8790778 | The significance of vasoactive intestinal polypeptide (VIP) in immunomodulation. | Adv Neuroimmunol | 1996 | https://conductscience.org/library/papers/8790778 | PubMed |
| 16 | 19109992 | VPAC and PAC receptors: From ligands to function. | Pharmacol Ther | 2009 | https://conductscience.org/library/papers/19109992 | PubMed |
| 17 | 11578532 | Differential expression of vasoactive intestinal polypeptide receptor 1 and 2 mRNA in murine intestinal T lymphocyte subtypes. | J Neuroendocrinol | 2001 | https://conductscience.org/library/papers/11578532 | PubMed |
| 18 | 15169929 | The significance of vasoactive intestinal peptide in immunomodulation. | Pharmacol Rev | 2004 | https://conductscience.org/library/papers/15169929 | PubMed |
| 19 | 9876240 | Vasoactive intestinal peptide in thymus: synthesis, receptors and biological actions. | Neuroimmunomodulation | 1999 | https://conductscience.org/library/papers/9876240 | PubMed |
| 20 | 8784257 | Differential expression of vasoactive intestinal peptide receptors 1 and 2 (VIP-R1 and VIP-R2) mRNA in murine lymphocytes. | J Neuroimmunol | 1996 | https://conductscience.org/library/papers/8784257 | PubMed |
Cited by6
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 6 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 36910129 | The G Protein-Coupled Receptor, VPAC1, Mediates Vasoactive Intestinal Peptide-Dependent Functional Homeostasis of the Gut Microbiota. | Gastro Hep Adv | 2022 | https://conductscience.org/library/papers/36910129 | PubMed |
| 35217172 | Hypoxia Is a Dominant Remodeler of the Effector T Cell Surface Proteome Relative to Activation and Regulatory T Cell Suppression. | Mol Cell Proteomics | 2022 | https://conductscience.org/library/papers/35217172 | PubMed |
| 27817774 | [Expression of vasoactive intestinal peptide in peripheral blood of children with hand, foot and mouth disease]. | Zhongguo Dang Dai Er Ke Za Zhi | 2016 | https://conductscience.org/library/papers/27817774 | PubMed |
| 24171157 | Illuminating the petite picture of T cell memory responses to Listeria monocytogenes. | Biomed Res Int | 2013 | https://conductscience.org/library/papers/24171157 | PubMed |
| 22290545 | Urokinase plasminogen activator receptor induced non-small cell lung cancer invasion and metastasis requires NHE1 transporter expression and transport activity. | Cell Oncol (Dordr) | 2012 | https://conductscience.org/library/papers/22290545 | PubMed |
| 21765981 | Vasoactive intestinal peptide signaling axis in human leukemia. | World J Biol Chem | 2011 | https://conductscience.org/library/papers/21765981 | PubMed |
Genes7
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CD28 | 940 | PubTator's text mining | https://conductscience.org/library/genes/940 | NCBI Gene |
| CD4 | 920 | PubTator's text mining | https://conductscience.org/library/genes/920 | NCBI Gene |
| CD8A | 925 | PubTator's text mining | https://conductscience.org/library/genes/925 | NCBI Gene |
| IL2 | 3558 | PubTator's text mining | https://conductscience.org/library/genes/3558 | NCBI Gene |
| VIP | 7432 | PubTator's text mining | https://conductscience.org/library/genes/7432 | NCBI Gene |
| VIPR1 | 7433 | PubTator's text mining | https://conductscience.org/library/genes/7433 | NCBI Gene |
| VIPR2 | 7434 | PubTator's text mining | https://conductscience.org/library/genes/7434 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/21396722
GET https://conductscience.org/api/papers/v1/21396722/references?page=2